Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07101458Not ApplicableActive Not Recruiting

The Eswatini PRISM Study on Adolescents Living With HIV

Role: collaborator

NCT07424846Phase 2Recruiting

Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial

Role: collaborator

NCT04233242Not ApplicableCompleted

Genotype-Informed Versus Empiric Management of VirEmia

Role: collaborator

NCT05173324Phase 3Not Yet Recruiting

Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial

Role: collaborator

All 4 trials loaded